Mesenchymal Stem Cell Exosomes(AVEM HealthCare)

间充质干细胞外泌体(AVEM HealthCare)

Report date: 2025/02/28 10:17:28

Base Information

Drug NameMesenchymal Stem Cell Exosomes(AVEM HealthCare)
Drug Alias NameMSC-exosomes(AVEM HealthCare)Ardoxso(AVEM HealthCare)
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAvem Healthcare LLC
China Registration ClassN/A

Develop Information

Active CompaniesAvem Healthcare LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A